Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 6Glioma 3Glioblastoma 2Stomach Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Neuroma, Acoustic 1Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Cerebrovascular Disorders 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Astrocytoma 1

Interventions

Magnetoencephalography 1Magnetic Resonance Imaging 1Fluorescein 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cerebrovascular Disorders × Fluorescein × CNS × Clear all
NCT02478346 2017-02-14

Fluoescein

AdventHealth

Phase 4 Unknown
200 enrolled
CNS

Brain Neoplasms, Cerebrovascular Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡